Individuals Discontinuing Anti-Obesity Jabs Gain Back Weight Far More Rapidly Compared to Dieters
Fresh analysis reveals that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop traditional diet and exercise regimens.
Research printed in a prominent medical journal shows that while overweight people often shed substantial amounts of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"People buying such drugs need to be informed of the danger of rapid rebound weight gain when the therapy concludes," warns researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting mass in about a year and a half.
Comparing Treatments
The analysis, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.
The team point out that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Fast Regain
Doctors believe the mode of action of the injections explains the accelerated regain.
The injections imitate a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making overeating far more likely."
A Lifelong Issue?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, given the high risk of weight regain, the therapy might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the persistent nature of excess weight," comparing it to managing conditions like diabetes.
Patient Testimonies
Individuals who have discontinued the jabs explain a sudden return of appetite.
"It was like a trigger flipping and you become ravenous," described one woman.
The struggle is compounded if patients have not developed permanent lifestyle or habit changes during therapy.
Widespread Adoption
Recent estimates show that a significant number of adults in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is more common among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while these medications are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle changes.